PRKN and cancer: Alteration of mitophagy efficiency due, for example, to genetic mutations of key genes, such as PINK1 or PRKN (PARKIN), has been associated with neurological disorders (e.g., Parkinson disease, cancer, heart failure, and aging [116]).